|
Volumn 40, Issue 10, 2000, Pages 783-791
|
Sumatriptan for the range of headaches in migraine sufferers: Results of the spectrum study
a,b,g b,c d e f f f
g
NONE
(United States)
|
Author keywords
Efficacy; Migraine; Migrainous; Spectrum; Sumatriptan; Tension type
|
Indexed keywords
ANTIMIGRAINE AGENT;
MONOAMINE OXIDASE INHIBITOR;
SEROTONIN AGONIST;
SUMATRIPTAN;
VASOCONSTRICTOR AGENT;
ADULT;
AGED;
ANALYTIC METHOD;
ANTINOCICEPTION;
ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DIAGNOSTIC APPROACH ROUTE;
DISEASE CLASSIFICATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SOCIETY;
MIGRAINE;
PRIORITY JOURNAL;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
TEMPORAL ARTERITIS;
TENSION HEADACHE;
TIME;
TREATMENT OUTCOME;
WORK DISABILITY;
HOSPITALIZATION;
MIDDLE AGED;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PERIODICITY;
ADMINISTRATION, ORAL;
ADULT;
CROSS-OVER STUDIES;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MIGRAINE DISORDERS;
PERIODICITY;
SEVERITY OF ILLNESS INDEX;
SUMATRIPTAN;
TENSION-TYPE HEADACHE;
TREATMENT OUTCOME;
VASOCONSTRICTOR AGENTS;
|
EID: 0034519937
PISSN: 00178748
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1526-4610.2000.00143.x Document Type: Article |
Times cited : (218)
|
References (10)
|